| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.8M | +32.0% |
| Cost of Revenue | $45.2M | +6.2% |
| R&D Expense | $314.4M | +30.3% |
| SG&A Expense | $178.2M | +60.8% |
| Operating Income | -$479.0M | -36.8% |
| Pre-tax Income | -$464.8M | -39.9% |
| Income Tax | -$1.1M | +72.3% |
| Net Income | -$463.7M | -41.3% |
| EPS (Basic) | -$1.69 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $594.4M | +51.8% |
| Current Assets | $714.3M | +63.0% |
| Total Assets | $1.45B | +121.6% |
| Current Liabilities | $187.5M | +101.2% |
| Long-term Debt | $19.0M | +1627.7% |
| Total Liabilities | $413.8M | +117.5% |
| Stockholders' Equity | $1.03B | +123.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$359.2M | -24.8% |
| Capital Expenditures | $13.7M | +14.6% |
| Investing Cash Flow | $260.1M | +2642.6% |
| Financing Cash Flow | $304.1M | +117.0% |
| Free Cash Flow | -$372.9M | -24.4% |
| -7.0% |
| EPS (Diluted) | -$1.69 | -7.0% |